ATI PHARMACOLOGY PROCTORED
EXAM QUESTIONS WITH CORRECT
ANSWERS & RATIONALES 2025
A mmprovider mmprescribes mmphenobarbital mmfor mma mmclient mmwho mmhas mma mmseizure
mmdisorder. mmThe mmmedication mmhas mma mmlong mmhalf-life mmof mm4 mmdays. mmHow mmmany mmtimes
mmper mmday mmshould mmthe mmnurse mmexpect mmto mmadminister mmthis mmmedication?
A. mmOne
B. mmTwo
C. mmThree
D. mmFour mm- mmANSWER: mmA. mmOne
(Medications mmwith mmlong mmhalf-lives mmremain mmat mmtheir mmtherapeutic mmlevels mmbetween
mmdoses mmfor mmlong mmperiods mmof mmtime. mmThe mmnurse mmshould mmexpect mmto mmadminister
mmthis mmmedication mmonce mma mmday.)
A mmstaff mmeducator mmis mmreviewing mmmedication mmdosages mmand mmfactors mmthat mminfluence
mmmedication mmmetabolism mmwith mma mmgroup mmof mmnurses mmat mman mmin-service
mmpresentation. mmWhich mmof mmthe mmfollowing mmfactors mmshould mmthe mmeducator mminclude mmas
mma mmreason mmto mmadminister mmlower mmmedication mmdosages? mm(Select mmall mmthat mmapply.)
A. mmIncreased mmrenal mmsecretion
B. mmIncreased mmmedication-metabolizing mmenzymes
C. mmLiver mmfailure
D. mmPeripheral mmvascular mmdisease
E. mmConcurrent mmuse mmof mmmedication mmthe mmsame mmpathway mmmetabolizes mm-
mmANSWER: mmC. mmLiver mmfailure
E. mmConcurrent mmuse mmof mmmedication mmthe mmsame mmpathway mmmetabolizes
C. mmLiver mmfailure mmdecreases mmmetabolism mmand mmthus mmincreases mmthe mmconcentration
mmof mma mmmedication. mmThis mmrequires mmdecreasing mmthe mmdosage.
E. mmWhen mmthe mmsame mmpathway mmmetabolizes mmtwo mmmedications, mmthey mmcompete mmfor
mmmetabolism, mmthereby mmincreasing mmthe mmconcentration mmof mmone mmor mmboth
mmmedications. mmThis mmrequires mmdecreasing mmthe mmdosage mmof mmone mmor mmboth
,A mmnurse mmis mmpreparing mmto mmadminister mmeye mmdrops mmto mma mmclient. mmWhich mmof mmthe
mmfollowing mmactions mmshould mmthe mmnurse mmtake? mm(Select mmall mmthat mmapply.)
A. mmHave mmthe mmclient mmlie mmon mmher mmside.
B. mmAsk mmthe mmclient mmto mmlook mmup mmat mmthe mmceiling.
C. mmTell mmthe mmclient mmto mmblink mmwhen mmthe mmdrops mmenter mmher mmeye.
D. mmDrop mmthe mmmedication mminto mmthe mmcenter mmof mmthe mmclient's mmconjunctival mmsac.
E. mmInstruct mmthe mmclient mmto mmclose mmher mmeye mmgently mmafter mminstillation mm- mmANSWER:
mmB. mmAsk mmthe mmclient mmto mmlook mmup mmat mmthe mmceiling.
D. mmDrop mmthe mmmedication mminto mmthe mmcenter mmof mmthe mmclient's mmconjunctival mmsac.
E. mmInstruct mmthe mmclient mmto mmclose mmher mmeye mmgently mmafter mminstillation
(B. mmThe mmclient mmshould mmlook mmupward mmto mmkeep mmthe mmdrops mmfrom mmfalling mmonto mmher
mmcornea.
D. mmThe mmnurse mmshould mmdrop mmthe mmmedication mminto mmthe mm
center mmof mmthe mmconjunctival mmsac mmto mmpromote mmdistribution.
E. mmThe mmclient mmshould mmclose mmher mmeye mmgently mmto mmpromote mmdistribution mmof mmthe
mmmedication)
A mmnurse mmis mmcompleting mmdischarge mmteaching mmfor mma mmclient mmwho mmhas mma mmnew
mmprescription mmfor mmtransdermal mmpatches. mmWhich mmof mmthe mmfollowing mmstatements
mmshould mmthe mmnurse mmidentify mmas mman mmindication mmthat mmthe mmclient mmunderstands mmthe
mminstructions?
A. mm"I mmwill mmclean mmthe mmsite mmwith mman mmalcohol mmswab mmbefore mmI mmapply mmthe mmpatch."
B. mm"I mmwill mmrotate mmthe mmapplication mmsites mmweekly."
C. mm"I mmwill mmapply mmthe mmpatch mmto mman mmarea mmof mmskin mmwith mmno mmhair." mm
D. mm"I mmwill mmplace mmthe mmnew mmpatch mmon mmthe mmsite mmof mmthe mmold mmpatch. mm- mmANSWER:
mmC. mm"I mmwill mmapply mmthe mmpatch mmto mman mmarea mmof mmskin mmwith mmno mmhair." mm
(The mmclient mmshould mmapply mmthe mmpatch mmto mma mmhairless mmarea mmof mmskin mmto mmpromote
mmabsorption mmof mmthe mmmedication.)
A mmnurse mmreviewing mma mmclient's mmmedical mmrecord mmnotes mma mmnew mmprescription mmfor
mmverifying mmthe mmtrough mmlevel mmof mmthe mmclient's mmmedication. mmWhich mmof mmthe mmfollowing
mmactions mmshould mmthe mmnurse mmtake?
A. mmObtain mma mmblood mmspecimen mmimmediately mmprior mmto mmadministering mmthe mmnext
mmdose mmof mmmedication.
B. mmVerify mmthat mmthe mmclient mmhas mmbeen mmtaking mmthe mmmedication mmfor mm24 mmhr mmbefore
mmobtaining mma mmblood mmspecimen.
C. mmAsk mmthe mmclient mmto mmprovide mma mmurine mmspecimen mmafter mmthe mmnext mmdose mmof
mmmedication.
D. mmAdminister mmthe mmmedication,and mmobtain mma mmblood mmspecimen mm30 mmmin mmlate mm-
mmANSWER: mmA. mmObtain mma mmblood mmspecimen mmimmediately mmprior mmto mmadministering
mmthe mmnext mmdose mmof mmmedication.
,(To mmverify mmtrough mmlevels mmof mma mmmedication, mmthe mmnurse mmshould mmobtain mma mmblood
mmspecimen mmimmediately mmbefore mmadministering mmthe mmnext mmdose mmof mmmedication.)
A mmnurse mmis mmpreparing mma mmclient's mmmedications. mmWhich mmof mmthe mmfollowing mmactions
mmshould mmthe mmnurse mmtake mmin mmfollowing mmlegal mmpractice mmguidelines? mm(Select mmall
mmthat mmapply.)
A. mmMaintain mmskill mmcompetency.
B. mmDetermine mmthe mmdosage.
C. mmMonitor mmfor mmadverse mmeffects.
D. mmSafeguard mmmedications.
E. mmIdentify mmthe mmclient's mmdiagnosis mm- mmANSWER: mmA. mmMaintain mmskill mmcompetency.
C. mmMonitor mmfor mmadverse mmeffects.
D. mmSafeguard mmmedications.
(A.maintaining mmskill mmcompetency mmand mmusing mmappropriate mmadministration
mmtechniques mmare mmlegal mmresponsibilities mmof mmthe mmnurse
C. mmA mmnurse mmis mmlegally mmresponsible mmfor mmmonitoring mmfor mmside mmand mmadverse
mmeffects mmof mmmedication
D. mmSafeguarding mmof mmmedications, mmsuch mmas mmcontrolled mmsubstances, mmis mma mmlegal
mmresponsibility mmof mmthe mmnurse)
A mmnurse mmreviewing mma mmclient's mmhealth mmrecord mmnotes mma mmnew mmprescription mmfor
mmLisinopril mm10 mmmg mmPO mmonce mmevery mmday. mmThe mmnurse mmshould mmidentify mmthis mmas
mmwhich mmof mmthe mmfollowing mmtypes mmof mmprescription?
A. mmSingle
B. mmStat
C. mmRoutine
D. mmStanding mm- mmANSWER: mmC. mmRoutine
(A mmroutine mmor mmstandard mmprescription mmidentifies mmmedications mmto mmgive mmon mma
mmregular mmschedule mmwith mmor mmwithout mma mmtermination mmdate mmor mma mmspecific mmnumber
mmof mmdoses. mmThe mmnurse mmwill mmadminister mm
this mmmedication mmevery mmday mmuntil mmthe mmprovider mmdiscontinues mmit.)
A mmnurse mmis mmreviewing mma mmnew mmprescription mmfor mmOndansetron mm4 mmmg mmPO mmPRN
mmfor mmnausea mmand mmvomiting mmfor mma mmclient mmwho mmhas mmHyperemesis mmGravidarum.
mmThe mmnurse mmshould mmclarify mmwhich mmof mmthe mmfollowing mmparts mmof mmthe mmprescription
mmwith mmthe mmprovider?
A. mmName
B. mmDosage
, C. mmRoute
D. mmFrequency mm- mmANSWER: mmD. mmFrequency
(This mmprescription mmdoes mmnot mminclude mmthe mmtime mmor mmfrequency mmof mmmedication
mmadministration. mmThe mmnurse mmmust mmclarify mmthis mmwith mmthe mmprescribing mmprovide)
A mmnurse mmis mmadmitting mma mmclient mmand mmcompleting mma mmpreassessment mmbefore
mmadministering mmmedications. mmWhich mmof mmthe mmfollowing mmdata mmshould mmthe mmnurse
mminclude mmin mmthe mmpreassessment? mm(Select mmall mmthat mmapply.)
A. mmUse mmof mmherbal mmteas
B. mmDaily mmfluid mmintake
C. mmCurrent mmhealth mmstatus
D. mmPrevious mmsurgical mmhistory
E. mmFood mmallergies mm- mmANSWER: mmA. mmUse mmof mmherbal mmteas
C. mmCurrent mmhealth mmstatus
E. mmFood mmallergies
(A. mmThe mmnurse mmshould mminquire mmabout mmthe mmclient's mmuse mmof mmherbal mmproducts,
mmwhich mmoften mmcontain mmcaffeine, mmprior mmto mmmedication mmadministration mmbecause
mmcaffeine mmcan mmaffect mmmedication mmbiotransformation
C. mmThe mmnurse mmshould mmreview mmthe mmclient's mmcurrent mmhealth mmstatus mmbecause mmnew
mmprescriptions mmcan mmcause mmalterations mmin mmcurrent mmhealth mmstatus
E. mmThe mmnurse mmshould mminquire mmabout mmfood mmallergies mmduring mmthe mmpreassessment
mmto mmidentify mmany mmpotential mmreactions mmor mminteractions)
A mmnurse mmorienting mma mmnewly mmlicensed mmnurse mmis mmreviewing mmthe mmprocedure mmfor
mmtaking mma mmtelephone mmprescription. mmWhich mmof mmthe mmfollowing mmstatements mmshould
mmthe mmnurse mmidentify mmas mman mmindication mmthat mmthe mmnewly mmlicensed mmnurse
mmunderstands mmthe mmprocess?
A. mm"A mmsecond mmnurse mmenters mmthe mmprescription mminto mmthe mmclient's mmmedical mmrecord."
B. mm"Another mmnurse mmshould mmlisten mmto mmthe mmphone mmcall."
C. mm"The mmprovider mmcan mmclarify mmthe mmprescription mmwhen mmhe mmsigns mmthe mmhealth
mmrecord."
D. mm"I mmshould mmomit mmthe mm'read mmback' mmif mmthis mmis mma mmone-time mmprescription mm-
mmANSWER: mmB. mm"Another mmnurse mmshould mmlisten mmto mmthe mmphone mmcall."
(A mmsecond mmnurse mmshould mmlisten mmto mma mmtelephone mmprescription mmto mmprevent mmerrors
mmin mmcommunication.)
A mmnurse mmis mmpreparing mmto mmadminister mmvancomycin mm1 mmg mmby mmintermittent mmIV
mmbolus. mmAvailable mmis mmvancomycin mm1 mmg mmin mm100 mmmL mmof mmdextrose mm5% mmin mmwater
mm(D5W) mmto mminfuse mmover mm45 mmmin. mmThe mmdrop mmfactor mmof mmthe mmmanual mmIV mmtubing
EXAM QUESTIONS WITH CORRECT
ANSWERS & RATIONALES 2025
A mmprovider mmprescribes mmphenobarbital mmfor mma mmclient mmwho mmhas mma mmseizure
mmdisorder. mmThe mmmedication mmhas mma mmlong mmhalf-life mmof mm4 mmdays. mmHow mmmany mmtimes
mmper mmday mmshould mmthe mmnurse mmexpect mmto mmadminister mmthis mmmedication?
A. mmOne
B. mmTwo
C. mmThree
D. mmFour mm- mmANSWER: mmA. mmOne
(Medications mmwith mmlong mmhalf-lives mmremain mmat mmtheir mmtherapeutic mmlevels mmbetween
mmdoses mmfor mmlong mmperiods mmof mmtime. mmThe mmnurse mmshould mmexpect mmto mmadminister
mmthis mmmedication mmonce mma mmday.)
A mmstaff mmeducator mmis mmreviewing mmmedication mmdosages mmand mmfactors mmthat mminfluence
mmmedication mmmetabolism mmwith mma mmgroup mmof mmnurses mmat mman mmin-service
mmpresentation. mmWhich mmof mmthe mmfollowing mmfactors mmshould mmthe mmeducator mminclude mmas
mma mmreason mmto mmadminister mmlower mmmedication mmdosages? mm(Select mmall mmthat mmapply.)
A. mmIncreased mmrenal mmsecretion
B. mmIncreased mmmedication-metabolizing mmenzymes
C. mmLiver mmfailure
D. mmPeripheral mmvascular mmdisease
E. mmConcurrent mmuse mmof mmmedication mmthe mmsame mmpathway mmmetabolizes mm-
mmANSWER: mmC. mmLiver mmfailure
E. mmConcurrent mmuse mmof mmmedication mmthe mmsame mmpathway mmmetabolizes
C. mmLiver mmfailure mmdecreases mmmetabolism mmand mmthus mmincreases mmthe mmconcentration
mmof mma mmmedication. mmThis mmrequires mmdecreasing mmthe mmdosage.
E. mmWhen mmthe mmsame mmpathway mmmetabolizes mmtwo mmmedications, mmthey mmcompete mmfor
mmmetabolism, mmthereby mmincreasing mmthe mmconcentration mmof mmone mmor mmboth
mmmedications. mmThis mmrequires mmdecreasing mmthe mmdosage mmof mmone mmor mmboth
,A mmnurse mmis mmpreparing mmto mmadminister mmeye mmdrops mmto mma mmclient. mmWhich mmof mmthe
mmfollowing mmactions mmshould mmthe mmnurse mmtake? mm(Select mmall mmthat mmapply.)
A. mmHave mmthe mmclient mmlie mmon mmher mmside.
B. mmAsk mmthe mmclient mmto mmlook mmup mmat mmthe mmceiling.
C. mmTell mmthe mmclient mmto mmblink mmwhen mmthe mmdrops mmenter mmher mmeye.
D. mmDrop mmthe mmmedication mminto mmthe mmcenter mmof mmthe mmclient's mmconjunctival mmsac.
E. mmInstruct mmthe mmclient mmto mmclose mmher mmeye mmgently mmafter mminstillation mm- mmANSWER:
mmB. mmAsk mmthe mmclient mmto mmlook mmup mmat mmthe mmceiling.
D. mmDrop mmthe mmmedication mminto mmthe mmcenter mmof mmthe mmclient's mmconjunctival mmsac.
E. mmInstruct mmthe mmclient mmto mmclose mmher mmeye mmgently mmafter mminstillation
(B. mmThe mmclient mmshould mmlook mmupward mmto mmkeep mmthe mmdrops mmfrom mmfalling mmonto mmher
mmcornea.
D. mmThe mmnurse mmshould mmdrop mmthe mmmedication mminto mmthe mm
center mmof mmthe mmconjunctival mmsac mmto mmpromote mmdistribution.
E. mmThe mmclient mmshould mmclose mmher mmeye mmgently mmto mmpromote mmdistribution mmof mmthe
mmmedication)
A mmnurse mmis mmcompleting mmdischarge mmteaching mmfor mma mmclient mmwho mmhas mma mmnew
mmprescription mmfor mmtransdermal mmpatches. mmWhich mmof mmthe mmfollowing mmstatements
mmshould mmthe mmnurse mmidentify mmas mman mmindication mmthat mmthe mmclient mmunderstands mmthe
mminstructions?
A. mm"I mmwill mmclean mmthe mmsite mmwith mman mmalcohol mmswab mmbefore mmI mmapply mmthe mmpatch."
B. mm"I mmwill mmrotate mmthe mmapplication mmsites mmweekly."
C. mm"I mmwill mmapply mmthe mmpatch mmto mman mmarea mmof mmskin mmwith mmno mmhair." mm
D. mm"I mmwill mmplace mmthe mmnew mmpatch mmon mmthe mmsite mmof mmthe mmold mmpatch. mm- mmANSWER:
mmC. mm"I mmwill mmapply mmthe mmpatch mmto mman mmarea mmof mmskin mmwith mmno mmhair." mm
(The mmclient mmshould mmapply mmthe mmpatch mmto mma mmhairless mmarea mmof mmskin mmto mmpromote
mmabsorption mmof mmthe mmmedication.)
A mmnurse mmreviewing mma mmclient's mmmedical mmrecord mmnotes mma mmnew mmprescription mmfor
mmverifying mmthe mmtrough mmlevel mmof mmthe mmclient's mmmedication. mmWhich mmof mmthe mmfollowing
mmactions mmshould mmthe mmnurse mmtake?
A. mmObtain mma mmblood mmspecimen mmimmediately mmprior mmto mmadministering mmthe mmnext
mmdose mmof mmmedication.
B. mmVerify mmthat mmthe mmclient mmhas mmbeen mmtaking mmthe mmmedication mmfor mm24 mmhr mmbefore
mmobtaining mma mmblood mmspecimen.
C. mmAsk mmthe mmclient mmto mmprovide mma mmurine mmspecimen mmafter mmthe mmnext mmdose mmof
mmmedication.
D. mmAdminister mmthe mmmedication,and mmobtain mma mmblood mmspecimen mm30 mmmin mmlate mm-
mmANSWER: mmA. mmObtain mma mmblood mmspecimen mmimmediately mmprior mmto mmadministering
mmthe mmnext mmdose mmof mmmedication.
,(To mmverify mmtrough mmlevels mmof mma mmmedication, mmthe mmnurse mmshould mmobtain mma mmblood
mmspecimen mmimmediately mmbefore mmadministering mmthe mmnext mmdose mmof mmmedication.)
A mmnurse mmis mmpreparing mma mmclient's mmmedications. mmWhich mmof mmthe mmfollowing mmactions
mmshould mmthe mmnurse mmtake mmin mmfollowing mmlegal mmpractice mmguidelines? mm(Select mmall
mmthat mmapply.)
A. mmMaintain mmskill mmcompetency.
B. mmDetermine mmthe mmdosage.
C. mmMonitor mmfor mmadverse mmeffects.
D. mmSafeguard mmmedications.
E. mmIdentify mmthe mmclient's mmdiagnosis mm- mmANSWER: mmA. mmMaintain mmskill mmcompetency.
C. mmMonitor mmfor mmadverse mmeffects.
D. mmSafeguard mmmedications.
(A.maintaining mmskill mmcompetency mmand mmusing mmappropriate mmadministration
mmtechniques mmare mmlegal mmresponsibilities mmof mmthe mmnurse
C. mmA mmnurse mmis mmlegally mmresponsible mmfor mmmonitoring mmfor mmside mmand mmadverse
mmeffects mmof mmmedication
D. mmSafeguarding mmof mmmedications, mmsuch mmas mmcontrolled mmsubstances, mmis mma mmlegal
mmresponsibility mmof mmthe mmnurse)
A mmnurse mmreviewing mma mmclient's mmhealth mmrecord mmnotes mma mmnew mmprescription mmfor
mmLisinopril mm10 mmmg mmPO mmonce mmevery mmday. mmThe mmnurse mmshould mmidentify mmthis mmas
mmwhich mmof mmthe mmfollowing mmtypes mmof mmprescription?
A. mmSingle
B. mmStat
C. mmRoutine
D. mmStanding mm- mmANSWER: mmC. mmRoutine
(A mmroutine mmor mmstandard mmprescription mmidentifies mmmedications mmto mmgive mmon mma
mmregular mmschedule mmwith mmor mmwithout mma mmtermination mmdate mmor mma mmspecific mmnumber
mmof mmdoses. mmThe mmnurse mmwill mmadminister mm
this mmmedication mmevery mmday mmuntil mmthe mmprovider mmdiscontinues mmit.)
A mmnurse mmis mmreviewing mma mmnew mmprescription mmfor mmOndansetron mm4 mmmg mmPO mmPRN
mmfor mmnausea mmand mmvomiting mmfor mma mmclient mmwho mmhas mmHyperemesis mmGravidarum.
mmThe mmnurse mmshould mmclarify mmwhich mmof mmthe mmfollowing mmparts mmof mmthe mmprescription
mmwith mmthe mmprovider?
A. mmName
B. mmDosage
, C. mmRoute
D. mmFrequency mm- mmANSWER: mmD. mmFrequency
(This mmprescription mmdoes mmnot mminclude mmthe mmtime mmor mmfrequency mmof mmmedication
mmadministration. mmThe mmnurse mmmust mmclarify mmthis mmwith mmthe mmprescribing mmprovide)
A mmnurse mmis mmadmitting mma mmclient mmand mmcompleting mma mmpreassessment mmbefore
mmadministering mmmedications. mmWhich mmof mmthe mmfollowing mmdata mmshould mmthe mmnurse
mminclude mmin mmthe mmpreassessment? mm(Select mmall mmthat mmapply.)
A. mmUse mmof mmherbal mmteas
B. mmDaily mmfluid mmintake
C. mmCurrent mmhealth mmstatus
D. mmPrevious mmsurgical mmhistory
E. mmFood mmallergies mm- mmANSWER: mmA. mmUse mmof mmherbal mmteas
C. mmCurrent mmhealth mmstatus
E. mmFood mmallergies
(A. mmThe mmnurse mmshould mminquire mmabout mmthe mmclient's mmuse mmof mmherbal mmproducts,
mmwhich mmoften mmcontain mmcaffeine, mmprior mmto mmmedication mmadministration mmbecause
mmcaffeine mmcan mmaffect mmmedication mmbiotransformation
C. mmThe mmnurse mmshould mmreview mmthe mmclient's mmcurrent mmhealth mmstatus mmbecause mmnew
mmprescriptions mmcan mmcause mmalterations mmin mmcurrent mmhealth mmstatus
E. mmThe mmnurse mmshould mminquire mmabout mmfood mmallergies mmduring mmthe mmpreassessment
mmto mmidentify mmany mmpotential mmreactions mmor mminteractions)
A mmnurse mmorienting mma mmnewly mmlicensed mmnurse mmis mmreviewing mmthe mmprocedure mmfor
mmtaking mma mmtelephone mmprescription. mmWhich mmof mmthe mmfollowing mmstatements mmshould
mmthe mmnurse mmidentify mmas mman mmindication mmthat mmthe mmnewly mmlicensed mmnurse
mmunderstands mmthe mmprocess?
A. mm"A mmsecond mmnurse mmenters mmthe mmprescription mminto mmthe mmclient's mmmedical mmrecord."
B. mm"Another mmnurse mmshould mmlisten mmto mmthe mmphone mmcall."
C. mm"The mmprovider mmcan mmclarify mmthe mmprescription mmwhen mmhe mmsigns mmthe mmhealth
mmrecord."
D. mm"I mmshould mmomit mmthe mm'read mmback' mmif mmthis mmis mma mmone-time mmprescription mm-
mmANSWER: mmB. mm"Another mmnurse mmshould mmlisten mmto mmthe mmphone mmcall."
(A mmsecond mmnurse mmshould mmlisten mmto mma mmtelephone mmprescription mmto mmprevent mmerrors
mmin mmcommunication.)
A mmnurse mmis mmpreparing mmto mmadminister mmvancomycin mm1 mmg mmby mmintermittent mmIV
mmbolus. mmAvailable mmis mmvancomycin mm1 mmg mmin mm100 mmmL mmof mmdextrose mm5% mmin mmwater
mm(D5W) mmto mminfuse mmover mm45 mmmin. mmThe mmdrop mmfactor mmof mmthe mmmanual mmIV mmtubing
